Novartis Ag (NVS) Shareholder Motco Decreased Stake by $4.13 Million

Novartis AG (NYSE:NVS) Corporate Logo

Motco’s holdings in Novartis Ag (NVS) is decreased by 51.27% based on its latest 2018Q3 regulatory filing with the SEC. The company’s stock rose 5.30% while stock markets declined as Motco sold 48,000 shares. At the end of 2018Q3, the 45,625 shares of the major pharmaceuticals company held by the institutional investor were valued at $3.93 million, down from 93,625 at the end of the previous reported quarter. Motco has risen its stake in Illinois Tool Works Inc. (NYSE:ITW) and also increased its holding in Abbvie Inc (NYSE:ABBV) by 41,775 shares in the quarter, for a total of 90,632 shares.

On January, 23 is expected Novartis AG (NYSE:NVS)’s earnings report, according to RTT. Analysts have expectation on stock’s EPS of $1.34. That’s up 11.67 % from last year’s $1.2 EPS. If EPS of $1.34 is announced the profit of NVS could be $3.10B giving it 16.19 P/E. Wall Street predicts 2.29 % EPS growth as of January, 23.

For more Novartis AG (NYSE:NVS) news published briefly go to: Seekingalpha.com, Seekingalpha.com, Nasdaq.com, Seekingalpha.com or Seekingalpha.com. The titles are as follows: “Tilray up 13% premarket on Sandoz partnership – Seeking Alpha” published on December 18, 2018, “Novartis acquires Tear Film Innovations – Seeking Alpha” on December 19, 2018, “Will Tilray’s Dealmaking Lift Tilray Stock in 2019? – Nasdaq” with a publish date: January 11, 2019, “Big Pharma returning to U.S. price hikes – Reuters – Seeking Alpha” and the last “FDA OKs Amneal’s generic Exelon Patch – Seeking Alpha” with publication date: January 14, 2019.

Novartis AG (NYSE:NVS) Ratings Coverage

Total analysts of 6 have positions in Novartis (NYSE:NVS) as follows: 5 rated it a “Buy”, 0 with “Sell” and 1 with “Hold”. The positive are 83%. Since July 19, 2018 according to StockzIntelligence Inc Novartis has 6 analyst reports. The company rating was upgraded by Barclays Capital on Thursday, July 19. The company rating was upgraded by Citigroup on Tuesday, September 11. On Monday, November 19 the stock has “Conviction Buy” rating by Goldman Sachs. On Tuesday, December 11 the firm earned “Buy” rating by Jefferies. On Monday, November 26 Cowen & Co upgraded Novartis AG (NYSE:NVS) to “Outperform” rating. In Monday, September 10 report Bank of America upgraded the stock to “Buy” rating.

Novartis AG (NYSE:NVS) Analyst Ratings Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.